Abstract
Abstract
Background
Substance use disorder (SUD) is associated with executive function (EF) deficits and sensory modulation dysfunction (SMD). Yet, these deficits are not addressed therapeutically. This study aims to examine the effectiveness of the Functional-Cognitive and Sensory Treatment (F-CaST) compared to standard care to improve everyday performance and behavior and length of stay at the therapeutic community (TC) in individuals with SUD. In addition, to assess the improvement in EF, sensory modulation, participation, self-efficacy, life satisfaction, and use of strategies within and between groups. Satisfaction with F-CaST will also be assessed.
Methods
Forty-eight participants from a community of men in a TC, aged 18–45 years will be randomly allocated to (i) F-CaST—(experimental group) providing sensory and EF strategies for improving daily function; (ii) standard care (control group) as provided in the TC. Assessments will be conducted by assessors blind to group allocation at 4 time points: T1- pre-intervention; T2- post-intervention; T3- 1-month follow-up; and T4- 3-month follow-up. Primary outcome measures will be everyday performance, assessed by the Canadian Occupational Performance Measure (COPM), behavior and length of stay in the TC; secondary outcome measures will assess EF, SMD. Semi-structured in-depth qualitative interviews will be conducted at T1, T2 and T4.
Discussion
We hypothesize that F-CaST will lead to improved everyday performance and longer length of stay in the TC, compared to the control group. If F-CaST will prove to be effective, cognitive and sensory strategies may be incorporated as an adjunctive intervention in SUD rehabilitation.
Trial registration: ClinicalTrials.gov NCT05647863 Registered on 13 December 2022, https://classic.clinicaltrials.gov/ct2/show/NCT05647863.
Funder
Department of Justice, Estates Committee
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM–5). Washington, DC: American Psychiatric Association; 2013.
2. Administration. Substance abuse and mental health services. key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Subst Abus Ment Heal Serv Adm. 2021;2021:51–8.
3. Bar-Or RL, Kor A, Jaljuli I, Lev-Ran S. The epidemiology of substance use disorders among the adult jewish population in Israel. Eur Addict Res. 2021;27(5):362–70.
4. Goplerud E, Hodge S, Benham T. Substance use cost calculator for US employers with an emphasis on prescription pain medication misuse. J Occupationl Environ Med. 2017;59(11):1063.
5. Phelps CL, Paniagua SM, Willcockson IU, Potter JS. The relationship between self-compassion and the risk for substance use disorder. Drug Alcohol Depend. 2018;183:78–81. https://doi.org/10.1016/j.drugalcdep.2017.10.026.